Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ASPN Stock Forecast 2026-2027
$5.92
Current Price
$490.63M
Market Cap
Buy 4
Hold 1
Sell 1
Wall St Analyst Ratings
Distance to ASPN Price Targets
+35.1%
To High Target of $8.00
+18.2%
To Median Target of $7.00
-32.4%
To Low Target of $4.00
ASPN Price Momentum
+5.0%
1 Week Change
+1.7%
1 Month Change
-3.9%
1 Year Change
+109.2%
Year-to-Date Change
-39.5%
From 52W High of $9.78
+157.4%
From 52W Low of $2.30
📊 TOP ANALYST CALLS
Did ASPN Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Aspen Aerogels is one of their latest high-conviction picks.
Latest ASPN Stock Price Targets & Analyst Predictions
Based on our analysis of 3 Wall Street analysts, ASPN has a bullish consensus with a median price target of $7.00 (ranging from $4.00 to $8.00). The overall analyst rating is Strong Buy (8.3/10). Currently trading at $5.92, the median forecast implies a 18.2% upside. This outlook is supported by 4 Buy, 1 Hold, and 1 Sell ratings.
Conversely, the most conservative target is provided by David Anderson at Barclays, suggesting a 32.4% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ASPN Analyst Ratings
4
Buy
1
Hold
1
Sell
ASPN Price Target Range
Low
$4.00
Average
$7.00
High
$8.00
Current: $5.92
Latest ASPN Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ASPN.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 11, 2026 | Barclays | David Anderson | Underweight | Maintains | $4.00 |
| Mar 5, 2026 | Barclays | Underweight | Maintains | $N/A | |
| Feb 26, 2026 | TD Cowen | Buy | Maintains | $N/A | |
| Feb 26, 2026 | Roth Capital | Buy | Maintains | $N/A | |
| Nov 7, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Nov 7, 2025 | Barclays | Underweight | Maintains | $N/A | |
| Aug 11, 2025 | Barclays | Underweight | Downgrade | $N/A | |
| Aug 8, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| May 29, 2025 | Barclays | Equal-Weight | Downgrade | $N/A | |
| Feb 19, 2025 | B. Riley Securities | Buy | Maintains | $N/A | |
| Feb 19, 2025 | Barclays | Overweight | Maintains | $N/A | |
| Feb 14, 2025 | Roth MKM | Buy | Maintains | $N/A | |
| Feb 14, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Feb 14, 2025 | Craig-Hallum | Buy | Maintains | $N/A | |
| Feb 13, 2025 | Seaport Global | Neutral | Downgrade | $N/A | |
| Jan 24, 2025 | Craig-Hallum | Buy | Maintains | $N/A | |
| Jan 16, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Nov 12, 2024 | Barclays | Overweight | Maintains | $N/A | |
| Nov 8, 2024 | Roth MKM | Buy | Maintains | $N/A | |
| Oct 22, 2024 | Piper Sandler | Overweight | Maintains | $N/A |
Aspen Aerogels Inc. (ASPN) Competitors
The following stocks are similar to Aspen Aerogels based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
ASPN
Aspen Aerogels
mkt cap
467.43M
Aspen Aerogels Inc. (ASPN) Financial Data
Aspen Aerogels Inc. has a market capitalization of $490.63M with a P/E ratio of 25.4x. The company generates $230.26M in trailing twelve-month revenue with a -48.6% profit margin.
Revenue growth is -51.9% quarter-over-quarter, while maintaining an operating margin of -53.9% and return on equity of -42.4%.
Valuation Metrics
Market Cap
$490.63M
Enterprise Value
$405.81M
P/E Ratio
25.4x
PEG Ratio
-0.3x
Price/Sales
2.1x
Growth & Margins
Revenue Growth (YoY)
-51.9%
Gross Margin
+11.3%
Operating Margin
-53.9%
Net Margin
-48.6%
EPS Growth
-51.9%
Financial Health
Cash/Price Ratio
+35.4%
Current Ratio
2.9x
Debt/Equity
60.3x
ROE
-42.4%
ROA
-6.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Aspen Aerogels Inc. (ASPN) Business Model
About Aspen Aerogels Inc.
What They Do
Develops advanced aerogel materials for thermal management.
Business Model
Aspen Aerogels generates revenue by designing, developing, and manufacturing specialized aerogel materials that cater to diverse industries such as energy, petrochemicals, and construction. Their products are essential for improving energy efficiency and sustainability, allowing businesses to reduce operational costs and environmental impact.
Additional Information
The company is based in Northborough, Massachusetts, and leverages innovations in nanotechnology to enhance its product offerings. With a focus on energy conservation and climate change mitigation, Aspen Aerogels is well-positioned to capitalize on the increasing global demand for sustainable technologies.
Company Information
Sector
Industrials
Industry
Building Products & Equipment
Employees
4,100
CEO
Mr. Donald A. Nolan
Country
United States
IPO Year
2014
Website
www.apog.comAspen Aerogels Inc. (ASPN) Latest News & Analysis
Latest News
Quick Summary
Aspen Aerogels, Inc. has been recognized as a 2025 General Motors Supplier of the Year, highlighting its role in aerogel-based sustainability and electrification solutions.
Why It Matters
Aspen Aerogels' recognition as a 2025 GM Supplier of the Year enhances its credibility and could lead to increased contracts, boosting revenue and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Aspen Aerogels (NYSE: ASPN) has begun a staged restart of manufacturing operations at its East Providence, Rhode Island facility, as announced on May 14, 2026.
Why It Matters
The restart of manufacturing at Aspen Aerogels signals potential revenue growth and improved operational efficiency, positively impacting the company's stock performance and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Aspen Aerogels Q1 Earnings Call Highlights
1 month ago
Quick Summary
Aspen Aerogels (NYSE: ASPN) anticipates sequential revenue growth through 2026, despite a first-quarter sales decline and a temporary shutdown at its Rhode Island facility.
Why It Matters
Aspen Aerogels' projected revenue growth through 2026, despite short-term challenges, indicates potential long-term value and resilience, impacting investor sentiment positively.
Source: MarketBeat
Market Sentiment:
Negative
Quick Summary
Aspen Aerogels, Inc. (ASPN) held its Q1 2026 earnings call, providing insights into financial performance and business updates.
Why It Matters
Aspen Aerogels' Q1 earnings call provides insights into financial performance and future prospects, impacting stock valuation and investment decisions.
Source: Seeking Alpha
Market Sentiment:
Neutral
Aspen Aerogels, Inc. Reports First Quarter 2026 Financial Results and Recent Business Highlights
1 month ago
Quick Summary
An East Providence manufacturing facility is set for a staged restart in May. The company reported a cash balance of $175.6 million, up from $158.6 million, and secured a subsea pipeline contract for Q3 2026.
Why It Matters
The restart of the East Providence facility and increased cash balance indicate operational recovery and financial strength, while the new pipeline contract suggests future revenue growth.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Aspen Aerogels (ASPN) reported a quarterly loss of $0.28 per share, exceeding the Zacks estimate of a $0.27 loss, and worsening from a $0.06 loss per share a year earlier.
Why It Matters
Aspen Aerogels' larger-than-expected quarterly loss signals ongoing financial struggles, potentially impacting investor confidence and stock performance.
Source: Zacks Investment Research
Market Sentiment:
Negative
Frequently Asked Questions About ASPN Stock
What is Aspen Aerogels Inc.'s (ASPN) stock forecast for 2026?
Based on our analysis of 3 Wall Street analysts, Aspen Aerogels Inc. (ASPN) has a median price target of $7.00. The highest price target is $8.00 and the lowest is $4.00.
Is ASPN stock a good investment in 2026?
According to current analyst ratings, ASPN has 4 Buy ratings, 1 Hold ratings, and 1 Sell ratings. The stock is currently trading at $5.92. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ASPN stock?
Wall Street analysts predict ASPN stock could reach $7.00 in the next 12 months. This represents a 18.2% increase from the current price of $5.92. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Aspen Aerogels Inc.'s business model?
Aspen Aerogels generates revenue by designing, developing, and manufacturing specialized aerogel materials that cater to diverse industries such as energy, petrochemicals, and construction. Their products are essential for improving energy efficiency and sustainability, allowing businesses to reduce operational costs and environmental impact.
What is the highest forecasted price for ASPN Aspen Aerogels Inc.?
The highest price target for ASPN is $8.00 from at , which represents a 35.1% increase from the current price of $5.92.
What is the lowest forecasted price for ASPN Aspen Aerogels Inc.?
The lowest price target for ASPN is $4.00 from David Anderson at Barclays, which represents a -32.4% decrease from the current price of $5.92.
What is the overall ASPN consensus from analysts for Aspen Aerogels Inc.?
The overall analyst consensus for ASPN is bullish. Out of 3 Wall Street analysts, 4 rate it as Buy, 1 as Hold, and 1 as Sell, with a median price target of $7.00.
How accurate are ASPN stock price projections?
Stock price projections, including those for Aspen Aerogels Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 13, 2026 3:27 PM UTC